EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Effects of Intravitreal Application of an Ozurdex Implant in Patients with Macular Edema due to Retinal Vein Occlusion

Martin Lada, Renata Ženíšková, Zuzana Hradcová, Jana Schützová, Jan Tesař, Jan Grygar, Jan Havlik, Martin Šín

Czech and Slovak Ophthalmology · 18.02.2026

DOI: 10.31348/2026/8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Czech and Slovak Ophthalmology, online erschienen am 18.02.2026. Verfasst von Martin Lada und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Macular Edema, Retinal Vein Occlusion, Dexamethasone, Glucocorticoids.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

A retrospective evaluation of the outcomes and safety of the Ozurdex implant in patients with cystoid macular edema (CME) due to retinal vein occlusion (RVO). Material and Methods: A retrospective analysis of 14 eyes (10 male patients, 4 female patients) treated with the Ozurdex implant at the application center of the Department of Ophthalmology at the Military University Hospital, with the indication of RVO. The period of monitored applications was from 2022 to 2024. Patients were followed up every two months for at least one year after the first application.The primary efficacy parameters assessed were: Best-corrected visual acuity (BCVA), Central retinal thickness (CRT), Intraocular pressure (IOP), Changes in the diameter of intraretinal cysts (IR), as the main OCT biomarker.

Results

At the first follow-up, two months after Ozurdex application, there was a statistically significant functional improvement, with an average increase of 4.7 letters ETDRS letters (p = 0.042). Six months after application, the average BCVA reached 58 letters ETDRS letters. CRT decreased by an average of 100 µm two months after the initial DEX implant. The highest and statistically significant increase in IOP (p = 0.008) was recorded two months after the application (with an average value of 20.9 mmHg).

Conclusion

Our results indicate that Ozurdex is a safe and effective second-line treatment for macular edema (ME) due to RVO. In our group, the best functional and anatomical results were achieved two months after application. By the fourth month, a decline in BCVA and an increase in CRT were observed. Between the fifth and sixth month, retreatment was necessary in some patients. Additionally, we confirmed that the greatest rise in IOP occurred two months post-application, which resolved spontaneously by the sixth month. In four patients, IOP values above 30 mmHg were recorded during follow-up, and the intraocular pressure was managed with medication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular EdemaRetinal Vein OcclusionDexamethasoneGlucocorticoidsHumansFemaleDrug ImplantsRetrospective StudiesMaleVisual AcuityIntravitreal InjectionsMiddle AgedAgedIntraocular PressureTreatment Outcome

Stichwörter der Autor:innen

Ozurdexbranch retinal vein occlusion (BRVO)central retinal vein occlusion (CRVO)dexamethasone (DEX)macular edema (ME)retinal vein occlusion (RVO)

Substanzen

Drug ImplantsDexamethasoneGlucocorticoids

Zitieren

APA

Lada, M., Ženíšková, R., Hradcová, Z., Schützová, J., Tesař, J., Grygar, J., Havlik, J., & Šín, M. (2026). Evaluation of the Effects of Intravitreal Application of an Ozurdex Implant in Patients with Macular Edema due to Retinal Vein Occlusion. Czech and Slovak Ophthalmology. https://doi.org/10.31348/2026/8

Vancouver

Lada M, Ženíšková R, Hradcová Z, Schützová J, Tesař J, Grygar J, et al. Evaluation of the Effects of Intravitreal Application of an Ozurdex Implant in Patients with Macular Edema due to Retinal Vein Occlusion. Czech and Slovak Ophthalmology. 2026. doi:10.31348/2026/8

BibTeX
@article{Lada2026,
  author = {Lada, Martin and Ženíšková, Renata and Hradcová, Zuzana and Schützová, Jana and Tesař, Jan and Grygar, Jan and Havlik, Jan and Šín, Martin},
  title = {Evaluation of the Effects of Intravitreal Application of an Ozurdex Implant in Patients with Macular Edema due to Retinal Vein Occlusion},
  journal = {Czech and Slovak Ophthalmology},
  year = {2026},
  doi = {10.31348/2026/8}
}
Kostenlos starten →